Skylands Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $7.7M | Buy |
166,365
+23,915
| +17% | +$1.11M | 1.12% | 26 |
|
2025
Q1 | $8.69M | Sell |
142,450
-21,225
| -13% | -$1.29M | 1.25% | 23 |
|
2024
Q4 | $9.26M | Sell |
163,675
-17,400
| -10% | -$984K | 1.29% | 22 |
|
2024
Q3 | $9.37M | Sell |
181,075
-39,725
| -18% | -$2.06M | 1.27% | 19 |
|
2024
Q2 | $9.17M | Buy |
220,800
+32,150
| +17% | +$1.34M | 1.3% | 21 |
|
2024
Q1 | $10.2M | Buy |
188,650
+9,625
| +5% | +$522K | 1.41% | 19 |
|
2023
Q4 | $9.19M | Sell |
179,025
-17,875
| -9% | -$917K | 1.35% | 18 |
|
2023
Q3 | $11.4M | Buy |
196,900
+14,850
| +8% | +$862K | 1.73% | 12 |
|
2023
Q2 | $11.6M | Sell |
182,050
-4,975
| -3% | -$318K | 1.67% | 13 |
|
2023
Q1 | $13M | Buy |
187,025
+71,800
| +62% | +$4.98M | 1.9% | 12 |
|
2022
Q4 | $8.29M | Sell |
115,225
-11,275
| -9% | -$811K | 1.31% | 20 |
|
2022
Q3 | $8.99M | Sell |
126,500
-4,400
| -3% | -$313K | 1.48% | 15 |
|
2022
Q2 | $10.1M | Sell |
130,900
-36,620
| -22% | -$2.82M | 1.48% | 18 |
|
2022
Q1 | $12.2M | Sell |
167,520
-32,025
| -16% | -$2.34M | 1.48% | 17 |
|
2021
Q4 | $12.4M | Buy |
199,545
+16,825
| +9% | +$1.05M | 1.44% | 17 |
|
2021
Q3 | $10.8M | Sell |
182,720
-19,500
| -10% | -$1.15M | 1.34% | 19 |
|
2021
Q2 | $13.4M | Sell |
202,220
-11,400
| -5% | -$756K | 1.59% | 15 |
|
2021
Q1 | $13.5M | Buy |
213,620
+23,810
| +13% | +$1.5M | 1.72% | 16 |
|
2020
Q4 | $11.8M | Buy |
189,810
+29,550
| +18% | +$1.83M | 1.71% | 18 |
|
2020
Q3 | $9.59M | Buy |
160,260
+14,800
| +10% | +$886K | 1.6% | 17 |
|
2020
Q2 | $8.55M | Buy |
145,460
+103,470
| +246% | +$6.08M | 1.51% | 16 |
|
2020
Q1 | $2.34M | Sell |
41,990
-250
| -0.6% | -$13.9K | 0.52% | 44 |
|
2019
Q4 | $2.69M | Buy |
+42,240
| New | +$2.69M | 0.39% | 55 |
|